Quoin Pharmaceuticals Ltd
For the period ended Dec 5, 2024. Filed Oct 24, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 5, 2024 · Filed Oct 24, 2024
Contents
PROXY STATEMENT SUMMARY
PROXY STATEMENT
FOR THE 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS
Thursday, December 5, 2024
PROXY STATEMENT SUMMARY
This summary highlights information contained elsewhere in this proxy statement. It does not contain all of the information you should consider, and you should read the entire proxy statement carefully before voting. References in this proxy statement to the “Company,” “Quoin,” “Quoin Ltd.,” “we,” “us,” and “our” refer to Quoin Pharmaceuticals Ltd., an Israeli company. The Notice of Annual General Meeting of Shareholders, proxy statement and a proxy card or voting instruction form, as applicable, are being distributed and made available to the holders of our ordinary shares, as well as holders of our ordinary shares that are represented by American Depositary Shares (“ADSs”), collectively referred to as “shareholders,” starting on or about October 24, 2024. Our principal executive offices are located at 42127 Pleasant Forest Ct., Ashburn, VA 20148.
Annual Meeting Information
| | Date and Time: | | | Thursday, December 5, 2024, beginning at 12:00 p.m., US Eastern Time | |
|---|---|---|---|---|---|
| | Meeting Place: | | | Offices of Blank Rome LLP located at One Logan Square, Philadelphia, PA 19103 | |
| | Record Date: | | | October 21, 2024 | |
| | Voting: | | | Each ordinary share is entitled to one vote per share on all matters presented at the Annual Meeting. Each ADS represents one of our ordinary shares. | |
It is important that your shares be represented and voted at the Annual Meeting. Shareholders should vote by marking, signing and dating the accompanying proxy card if you hold ordinary shares, or voting instruction form if you hold ordinary shares represented by ADSs, and returning it promptly. If your shares are held in an account at a bank, broker or other nominee, please check the materials provided to you by your broker, bank or other nominee to determine how you may vote your shares.
Voting Matters and the Board’s Recommendation
| Agenda Item | | | Board Vote Recommendation | | | Page Reference | |
|---|---|---|---|---|---|---|---|
| Election of seven directors | | | FOR each Director Nominee | | | 7 | |
| Approval of certain amendments to our Amended and Restated Articles of Association, as amended | | | FOR | | | 23 | |
| Approval of a compensation program for Dr. Michael Myers, our Chief Executive Officer and Chairman of the Board | | | FOR | | | 25 | |
| Approval of a compensation program for Denise Carter, our Chief Operating Officer and member of the Board | | | FOR | | | 27 | |
| Approval of changes to our non-employee directors’ compensation program | | | FOR | | | 29 | |
| Appointment of Marcum LLP to serve as our independent registered public accounting firm until our next annual general meeting of shareholders | | | FOR | | | 30 | |
| Subject to his re-election, approval of Dr. Michael Myers’ service as both the Company’s Chief Executive Officer and Chairman of the Board for a period of three years | | | FOR | | | 32 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.